Announcement
16 Mar 2020
In March 2020, the USTR announced a set of exclusions from the additional tariffs on a number of medical products from China.
Source
Sign in to access
Number of interventions
1
0 certainly harmful
0 likely harmful
1 liberalising
List of interventions
Implementation date
24 Sep 2018
Revocation date:
01 Jun 2024
Prolonged: 01 Jun 2024
Import tariff
On 16 March 2020, the United States Trade Representative (USTR) announced a set of exclusions from the additional 25% tariff on a number of medical products from China. The decision is taken in respon...
Sign in to see more
Related State Acts
Prolonged: 01 Dec 2025
United States of America: US Administration provides temporary exclusions on Section 301 tariffs from China (extended until November 2026)
Implemented: 30 Sep 2023
United States of America: USTR excludes medical products from China Section 301 Tariffs
End prolongation: 30 Nov 2021
United States of America: COVID-19 exclusions from China Section 301 Tariffs
End prolongation: 14 Jun 2024
United States of America: Retaliation against China for intellectual property practices
Threads
See all
Liberalising Trade Policy Measures
This Thread tracks liberalising trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
14451
interventions
186
jurisdictions